MRVI
Price:
$9.05
Market Cap:
$2.28B
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and ...[Read more]
Industry
Biotechnology
IPO Date
2020-11-20
Stock Exchange
NASDAQ
Ticker
MRVI
According to Maravai LifeSciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.00. This represents a change of 4.49% compared to the average of 9.57 of the last 4 quarters.
The mean historical Current Ratio of Maravai LifeSciences Holdings, Inc. over the last ten years is 4.95. The current 10.00 Current Ratio has changed 20.12% with respect to the historical average. Over the past ten years (40 quarters), MRVI's Current Ratio was at its highest in in the March 2024 quarter at 11.32. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
4.95
Median
5.12
Minimum
1.50
Maximum
8.00
Discovering the peaks and valleys of Maravai LifeSciences Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 211.23%
Maximum Annual Current Ratio = 8.00
Minimum Annual Increase = -2.45%
Minimum Annual Current Ratio = 1.50
Year | Current Ratio | Change |
---|---|---|
2023 | 8.00 | 3.95% |
2022 | 7.70 | -2.45% |
2021 | 7.89 | 211.23% |
2020 | 2.54 | 23.79% |
2019 | 2.05 | 36.75% |
The current Current Ratio of Maravai LifeSciences Holdings, Inc. (MRVI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.86
5-year avg
5.64
10-year avg
4.95
Maravai LifeSciences Holdings, Inc.’s Current Ratio is less than Roivant Sciences Ltd. (27.91), greater than Krystal Biotech, Inc. (9.50), less than Prometheus Biosciences, Inc. (37.56), less than Akero Therapeutics, Inc. (24.89), greater than Apellis Pharmaceuticals, Inc. (5.08), greater than Halozyme Therapeutics, Inc. (7.41), less than Agios Pharmaceuticals, Inc. (10.09), greater than Insmed Incorporated (2.71), less than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Ultragenyx Pharmaceutical Inc. (3.54), greater than Alector, Inc. (3.52), greater than Legend Biotech Corporation (4.84), greater than Ascendis Pharma A/S (0.74), less than Cytokinetics, Incorporated (10.39), less than Edgewise Therapeutics, Inc. (30.24), greater than Amicus Therapeutics, Inc. (2.75), greater than Incyte Corporation (1.92), less than Denali Therapeutics Inc. (12.46), greater than argenx SE (8.53), greater than Harmony Biosciences Holdings, Inc. (3.13), greater than Arbutus Biopharma Corporation (6.56), less than Immunovant, Inc. (13.08), greater than Arcutis Biotherapeutics, Inc. (8.46), less than Protagonist Therapeutics, Inc. (13.73),
Company | Current Ratio | Market cap |
---|---|---|
27.91 | $9.10B | |
9.50 | $5.29B | |
37.56 | $9.56B | |
24.89 | $1.83B | |
5.08 | $5.00B | |
7.41 | $7.50B | |
10.09 | $2.46B | |
2.71 | $12.21B | |
10.22 | $8.19B | |
3.54 | $5.09B | |
3.52 | $472.01M | |
4.84 | $9.90B | |
0.74 | $6.83B | |
10.39 | $6.36B | |
30.24 | $1.64B | |
2.75 | $3.46B | |
1.92 | $11.80B | |
12.46 | $3.61B | |
8.53 | $32.41B | |
3.13 | $2.02B | |
6.56 | $858.96M | |
13.08 | $4.98B | |
8.46 | $1.21B | |
13.73 | $2.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Maravai LifeSciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Maravai LifeSciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Maravai LifeSciences Holdings, Inc.'s Current Ratio?
How is the Current Ratio calculated for Maravai LifeSciences Holdings, Inc. (MRVI)?
What is the highest Current Ratio for Maravai LifeSciences Holdings, Inc. (MRVI)?
What is the 3-year average Current Ratio for Maravai LifeSciences Holdings, Inc. (MRVI)?
What is the 5-year average Current Ratio for Maravai LifeSciences Holdings, Inc. (MRVI)?
How does the current Current Ratio for Maravai LifeSciences Holdings, Inc. (MRVI) compare to its historical average?